![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
CalciMedica, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for life-threatening inflammatory diseases with high unmet needs. Its technology targets the inhibition of Calcium Release-Activated Calcium (CRAC) channels designed to modulate the immune... CalciMedica, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for life-threatening inflammatory diseases with high unmet needs. Its technology targets the inhibition of Calcium Release-Activated Calcium (CRAC) channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases. CRAC channels serve to replenish calcium levels in the endoplasmic reticulum (ER) and provide calcium for cellular signaling events. Its lead product candidate, Auxora, is an intravenous-formulated, small molecule CRAC channel inhibitor. Auxora has the capability to modulate the immune response and protect against tissue cell injury, addressing inflammatory diseases, such as acute pancreatitis (AP), asparaginase-associated acute pancreatitis (AAP), acute kidney injury (AKI), and acute hypoxemic respiratory failure. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1407 | -5.28808208366 | 2.6607 | 2.75 | 2.555 | 15724 | 2.69958712 | CS |
4 | -0.61 | -19.4888178914 | 3.13 | 3.2808 | 2.32 | 32404 | 2.68878092 | CS |
12 | -0.84 | -25 | 3.36 | 3.67 | 2.05 | 44438 | 2.91381496 | CS |
26 | -2.15 | -46.0385438972 | 4.67 | 5.97 | 2.05 | 48964 | 3.64741864 | CS |
52 | -3.03 | -54.5945945946 | 5.55 | 6.265 | 2.05 | 39929 | 3.91138464 | CS |
156 | -13.86 | -84.6153846154 | 16.38 | 16.38 | 1.17 | 17609 | 3.91855574 | CS |
260 | -13.86 | -84.6153846154 | 16.38 | 16.38 | 1.17 | 12072 | 3.91855574 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions